Metraipolis › archive › dc_c8183dcbc436

MPL receptor dimerization and the thrombopoietin pathway in primary immune thrombocytopenia: from molecular mechanisms to targeted therapies — Europe PMC PMID:42338948

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42338948
DOI: 10.3389/fmed.2026.1798504
License (as archived): solo-consultazione
Archived: 2026-10-31T16:50:39.439Z
SHA-256 of the archived text: 32261c116c693d75f2b6c74e089861e4a4d9a7e656f13f5e71950d652dd18cce
Stable URL of this page: https://metraipolis.com/documento/dc_c8183dcbc436

How to cite

MPL receptor dimerization and the thrombopoietin pathway in primary immune thrombocytopenia: from molecular mechanisms to targeted therapies — Europe PMC PMID:42338948 — Europe PMC (en), https://europepmc.org/article/MED/42338948 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c8183dcbc436 (Metraipolis archive dc_c8183dcbc436, sha256 32261c116c693d75f2b6c74e089861e4a4d9a7e656f13f5e71950d652dd18cce)

BibTeX

@misc{dcc8183dcbc436,
  title = {MPL receptor dimerization and the thrombopoietin pathway in primary immune thrombocytopenia: from molecular mechanisms to targeted therapies — Europe PMC PMID:42338948},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42338948},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c8183dcbc436; sha256 32261c116c693d75f2b6c74e089861e4a4d9a7e656f13f5e71950d652dd18cce},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42338948. Agents can read the archived copy with the MCP tool read_document.